| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 31.98▼ | 31.91▲ | 31.93▲ | 32.13▼ | 29.80▲ |
| MA10 | 31.92▲ | 31.97▼ | 31.91▲ | 31.76▲ | 27.15▲ |
| MA20 | 31.95▲ | 31.78▲ | 31.89▲ | 30.71▲ | 24.72▲ |
| MA50 | 31.92▲ | 32.16▼ | 31.92▲ | 27.01▲ | N/A |
| MA100 | 31.85▲ | 31.81▲ | 31.64▲ | 24.53▲ | N/A |
| MA200 | 32.23▼ | 31.58▲ | 29.00▲ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | 0.029▲ | 0.007▲ | -0.092▼ | N/A |
| RSI | 50.540▲ | 51.124▲ | 50.263▲ | 62.242▲ | 75.051▲ |
| STOCH | 62.478 | 26.085 | 58.236 | 57.176 | 76.438 |
| WILL %R | -53.030 | -58.857 | -36.655 | -43.353 | -11.700▲ |
| CCI | 48.028 | 11.803 | 52.218 | 23.281 | 145.250▲ |
| MA | $LBRX Price Crossed Below MA(7) | Set Alert |
|
Wednesday, April 22, 2026 04:47 PM
Pivotal Phase 3 NOVA-2 trial in schizophrenia ongoing, topline data expected in 2H 2027LB-102 has potential to be the first benzamide approved ...
|
|
Tuesday, February 10, 2026 01:42 PM
NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (LBRX) today announced that it has granted to Dr. Minako Pazdera, the new General Counsel of LB Pharmaceuticals, an equity award ...
|
|
Tuesday, February 10, 2026 08:41 AM
NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced that it has granted to Dr. Minako Pazdera, the new General ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/05/26 | 31.68 | 32.825 | 30.66 | 31.97 | 68,265 |
| 07/05/26 | 32.09 | 32.13 | 31.06 | 31.98 | 85,566 |
| 06/05/26 | 33.43 | 33.43 | 31.48 | 32.00 | 218,400 |
| 05/05/26 | 32.07 | 33.21 | 31.82 | 32.88 | 110,823 |
| 04/05/26 | 31.29 | 32.47 | 31.29 | 31.83 | 122,293 |
| 01/05/26 | 31.61 | 32.255 | 30.89 | 31.43 | 124,609 |
| 30/04/26 | 30.50 | 31.86 | 30.46 | 31.71 | 146,995 |
| 29/04/26 | 31.015 | 31.65 | 30.21 | 30.59 | 145,426 |
| 28/04/26 | 31.76 | 33.00 | 30.62 | 31.38 | 110,815 |
| 27/04/26 | 30.93 | 33.47 | 30.93 | 31.81 | 239,583 |
|
|
||||
|
|
||||
|
|